Adverse reaction to statins ‘linked to increased CVD risk’
Patients experiencing a reaction will need careful management to ensure they stay on lipid-lowering therapy, researchers say.
Tag: Statins
When should you add in a non-statin therapy?
New global guidance recommends when to use ezetimibe and PCSK9 inhibitors in hard-to-treat patients at high risk of a CVD event.
Which statins are best for lowering non-HDL cholesterol in high-risk patients?
A meta-analysis ranks the agents depending on the intensity of treatment required for cardio protection of patients with diabetes…
Our new study questions the benefits of statins, again
Cholesterol-lowering statins are one of the world’s most commonly used medicines. They were first approved for people with a high risk of cardiovascular disease in…
Fewer than one in 10 patients statin intolerant: study
World's largest study shows less than 10% of patients have side effects from the drug.
New evidence on statins and diabetes controversy
Large study in US veterans with diabetes shows a dose-response effect, researchers say.
Gene-silencing to curb LDL-C ‘could dramatically cut CVD risk’
Researchers have attempted to simulate a 50-year randomised controlled trial.
Statins ‘reduce liver cancer risk’ in NASH cirrhosis
The observational study shows a dose-response effect, researchers say.
‘No link’ between statins and dementia in over-65s
The analysis of results from ASPREE cofirms earlier studies, expert comentator says.
Are PCSK9 inhibitors preferable to statins in patients with stroke risk?
A meta-analysis links statins to an increased risk of haemorrhagic stroke in a dose-dependent manner.
